Lhasa Shengtai Information Technology Company Limited, a subsidiary of Chinese energy & chemical player Inner Mongolia Junzheng Energy & Chemical Group Co.Ltd, is set to acquire 31.17 per cent stake in biotech firm Wuhan Docan Pharmaceutical Co.,Ltd for 1.12 billion yuan ($160 million), per a filing with the Shanghai Stock Exchange (SSE).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
